10-Q: Oscar Health Reports Strong Q1 2024 Results, Driven by Membership Growth and Improved Margins

Oscar Health's first quarter of 2024 saw a significant increase in revenue and a return to profitability, driven by membership growth and improved cost management.

Summary

• Oscar Health reported a net income of $177.4 million for the first quarter of 2024, a significant turnaround from a net loss of $39.6 million in the same period last year.
• Total revenue increased by 47% year-over-year to $2.14 billion, primarily driven by a 42% increase in membership to 1.45 million members.
• Premium revenue reached $2.09 billion, up from $1.43 billion in Q1 2023, due to higher membership, rate increases, and lower risk adjustment as a percentage of premiums.
• The Medical Loss Ratio (MLR) improved to 74.2% from 76.3% in the prior year, reflecting better cost management and pricing strategies.
• Adjusted EBITDA was $219.3 million, compared to $51.1 million in the first quarter of 2023.
• The company's cash and cash equivalents totaled $2.23 billion as of March 31, 2024, up from $1.87 billion at the end of 2023.

Sentiment

Score: 8

Explanation: The document reflects a strong positive sentiment due to the company's return to profitability, significant revenue growth, and improved cost management. The non-renewal of the Cigna partnership and the cybersecurity incident are minor concerns compared to the overall positive financial performance.

Positives

• The company achieved a significant turnaround to profitability in Q1 2024.
• Membership growth was strong, increasing by 42% year-over-year.
• The Medical Loss Ratio improved, indicating better cost management and pricing.
• The company's cash position improved significantly.
• The company's investment income increased by 19% due to higher yields and interest rates.

Negatives

• The company is not renewing its Cigna+Oscar Small Group arrangement after December 31, 2024.
• The company experienced a cybersecurity incident at Change Healthcare, though it did not have a material impact on financials.
• Depreciation and amortization expenses increased by 58% due to an increase in internally developed software placed into service.

Risks

• The company faces heightened competition in the health insurance market.
• There are risks associated with accurately estimating medical expenses and managing medical costs.
• Changes in federal or state laws, including the Affordable Care Act, could impact the business.
• The company is subject to ongoing regulatory requirements, including capital reserve and surplus requirements.
• Unfavorable outcomes from lawsuits, audits, and investigations could negatively affect the company.
• Data security breaches of the company's or its partners' systems pose a risk.
• The company's ability to attract and retain qualified personnel is a risk.
• The company's risk adjustment estimates are subject to a high degree of estimation and variability.

Future Outlook

The company expects to continue to focus on membership growth, cost management, and leveraging its technology platform to improve member experience and drive profitability. The company will continue to offer the Cigna+Oscar Small Group product through December 15, 2024, and provide transition and run-off services through December 31, 2026.

Management Comments

• Management believes that the company's operational and financial measures are useful in evaluating performance.
• Management believes that the company's reinsurance agreements help achieve important goals for the business, including risk management and capital efficiency.
• Management believes that the company's cash, cash equivalents, and investments will be sufficient to fund operating requirements for at least the next twelve months.

Industry Context

The company's performance is being driven by strong growth in the ACA marketplace, which has seen a 30% increase in enrollment for plan year 2024. The company's exit from the Medicare Advantage market and the non-renewal of the Cigna+Oscar partnership are strategic decisions that will impact future results.

Comparison to Industry Standards

• Oscar Health's improvement in MLR to 74.2% is a positive sign, as many health insurers aim for an MLR below 80%.
• The company's membership growth of 42% is significant, indicating strong market demand for its plans.
• The return to profitability and the substantial increase in Adjusted EBITDA suggest that the company is making progress in achieving financial sustainability.
• Comparatively, other tech-enabled health insurers such as Bright Health and Clover Health have struggled with profitability and high MLRs, making Oscar's performance stand out.
• The company's focus on its technology platform and member experience aligns with industry trends towards personalized and digital healthcare solutions.

Management Changes

Legal Proceedings

• The company is involved in a securities class action lawsuit related to its IPO, but believes it has meritorious defenses.
• The company is subject to reviews by various state insurance and healthcare regulatory authorities.

Related Party Transactions

• The company issued convertible senior notes to funds affiliated with Dragoneer Investment Group, Thrive Capital Management, LionTree Investment Management, and Tenere Capital LLC.

Stakeholder Impact

• Shareholders will benefit from the company's improved financial performance and return to profitability.
• Employees may benefit from the company's growth and success.
• Customers may benefit from the company's focus on improving member experience.
• The non-renewal of the Cigna+Oscar partnership may impact some customers and partners.

Next Steps

• The company will continue to focus on membership growth and cost management.
• The company will manage the transition of the Cigna+Oscar partnership.
• The company will continue to leverage its technology platform to improve member experience.

Key Dates

Keywords

health insurance, membership growth, medical loss ratio, profitability, risk adjustment, EBITDA, technology platform, healthcare, insurance, financial results